Abstract
In diverse organisms, calorie restriction slows the pace of ageing and increases maximum lifespan. In the budding yeast cerevisiae, calorie restriction extends lifespan by the activity of Sir2 (ref. 1), a member of the conserved sirtuin family of NAD+-dependent protein deacetylases. Included in this family are SIR-2.1, a Caenorhabditis elegans enzyme that regulates lifespan, and SIRT1, a human deacetylase that cell survival by negatively regulating the p53 tumour suppressor. Here we report the discovery of three classes of small molecules that activate sirtuins. We show that the potent activator resveratrol, a polyphenol found in red wine, lowers the Michaelis constant of SIRT1 for both the acetylated substrate and NAD +, and increases cell survival by stimulating SIRT1-dependent deacetylation of p53. In yeast, resveratrol mimics calorie restriction by stimulating Sir2, increasing DNA stability and extending lifespan by 70%. We discuss possible evolutionary origins of this phenomenon and suggest new lines of research into the therapeutic use of sirtuin activators.
Original language | English |
---|---|
Pages (from-to) | 191-196 |
Number of pages | 6 |
Journal | Nature |
Volume | 425 |
Issue number | 6954 |
DOIs | |
State | Published - 11 Sep 2003 |
Externally published | Yes |
Bibliographical note
Funding Information:Acknowledgements We wish to thank members of the Sinclair and BIOMOL laboratories for discussions and manuscript preparation, S. Luikenhuis and J. Fox for critical reading of the manuscript, and R. Frye for reagents. This work was supported by the National Institute on Aging and the Harvard-Armenise Foundation. D.S. is an Ellison Medical Research Foundation New Research Scholar. K.B. is a Harvard Medical School Pathology Department MPM Scholar. H.C. is supported by the American Federation of Aging Research, D.L. by a National Eye Institute training grant, and J.W. by an NSF Fellowship.
Funding Information:
Acknowledgements We thank M. Ludwig for technical assistance; R. Viana for construction of the His6-POL30 vector used for the Supplementary Information; M. Hochstrasser for the ulp1ts and ulp2 mutants; C. Hoege and S. Jentsch for the anti-PCNA antibody used for the Supplementary Information; and W. Kramer for comments on the manuscript. R. Kahmann is acknowledged for generous support. H.D.U. is supported by grants from the German Ministry for Education and Research, Deutsche Forschungsgemeinschaft and the German–Israeli Foundation for Scientific Research and Development.
Funding
Acknowledgements We wish to thank members of the Sinclair and BIOMOL laboratories for discussions and manuscript preparation, S. Luikenhuis and J. Fox for critical reading of the manuscript, and R. Frye for reagents. This work was supported by the National Institute on Aging and the Harvard-Armenise Foundation. D.S. is an Ellison Medical Research Foundation New Research Scholar. K.B. is a Harvard Medical School Pathology Department MPM Scholar. H.C. is supported by the American Federation of Aging Research, D.L. by a National Eye Institute training grant, and J.W. by an NSF Fellowship. Acknowledgements We thank M. Ludwig for technical assistance; R. Viana for construction of the His6-POL30 vector used for the Supplementary Information; M. Hochstrasser for the ulp1ts and ulp2 mutants; C. Hoege and S. Jentsch for the anti-PCNA antibody used for the Supplementary Information; and W. Kramer for comments on the manuscript. R. Kahmann is acknowledged for generous support. H.D.U. is supported by grants from the German Ministry for Education and Research, Deutsche Forschungsgemeinschaft and the German–Israeli Foundation for Scientific Research and Development.
Funders | Funder number |
---|---|
Harvard-Armenise Foundation | |
National Science Foundation | |
National Institute on Aging | P01AG027916 |
National Eye Institute | |
AMERICAN FEDERATION FOR AGING RESEARCH | |
Deutsche Forschungsgemeinschaft | |
German-Israeli Foundation for Scientific Research and Development | |
Bundesministerium für Bildung und Forschung |